E-cigarette Nicotine Pharmacokinetic Study

NCT03178981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2022-12-07

No results posted yet for this study

Summary

This study will compare nicotine delivery and product satisfaction in healthy subjects either using several different types of electronic cigarettes or smoking a conventional cigarette.

Conditions

  • Healthy Volunteers
  • Smoking

Interventions

OTHER

Use electronic cigarette or smoke conventional cigarette

Use of electronic cigarette or smoking conventional cigarette ad libitum for 5 minute period

Sponsors & Collaborators

  • LA Clinical Trials

    collaborator OTHER
  • British American Tobacco (Investments) Limited

    lead INDUSTRY

Principal Investigators

  • Mitchell Nides, PhD · Los Angeles Clinical Trials

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-26
Primary Completion
2017-09-08
Completion
2017-09-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03178981 on ClinicalTrials.gov